Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3476879)

Published in Diabetes Care on July 26, 2012

Authors

Antti-Jussi Pyykkönen1, Bo Isomaa, Anu-Katriina Pesonen, Johan G Eriksson, Leif Groop, Tiinamaija Tuomi, Katri Räikkönen

Author Affiliations

1: Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland.

Articles cited by this

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess (1996) 16.96

Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med (1999) 12.71

Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA (1989) 10.82

Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care (2008) 7.27

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol (1985) (2005) 6.47

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol (2004) 5.26

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care (2009) 5.13

Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A (2008) 4.93

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet (2008) 4.84

Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia (2006) 4.71

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35

Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87

Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes (2002) 3.14

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81

Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA (1999) 2.71

Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care (2004) 2.63

Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax (2008) 2.02

Alterations in Glucose Disposal in Sleep-disordered Breathing. Am J Respir Crit Care Med (2008) 2.01

Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia (2005) 2.00

Basic Nordic Sleep Questionnaire (BNSQ): a quantitated measure of subjective sleep complaints. J Sleep Res (1995) 1.78

Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study. Diabetes Care (2011) 1.70

Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care (2008) 1.65

Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens (2001) 1.52

Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry (1998) 1.49

A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia (2010) 1.22

Stressful life events and the metabolic syndrome: the prevalence, prediction and prevention of diabetes (PPP)-Botnia Study. Diabetes Care (2009) 1.07

Impaired glucose tolerance in sleep disorders. PLoS One (2010) 1.05

Poor sleep and cardiovascular function in children. Hypertension (2011) 1.02

Poor sleep and altered hypothalamic-pituitary-adrenocortical and sympatho-adrenal-medullary system activity in children. J Clin Endocrinol Metab (2010) 1.01

The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract (2005) 0.94

High baseline insulin levels associated with 6-year incident observed sleep apnea. Diabetes Care (2010) 0.92

Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med (2011) 0.91

Sex-specific associations between sleep problems and hypothalamic-pituitary-adrenocortical axis activity in children. Psychoneuroendocrinology (2011) 0.89

Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study. Diabetes Care (2011) 0.84

Articles by these authors

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Identification of ten loci associated with height highlights new biological pathways in human growth. Nat Genet (2008) 16.25

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med (2008) 9.83

Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet (2008) 9.39

Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med (2008) 8.70

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Discerning the ancestry of European Americans in genetic association studies. PLoS Genet (2007) 7.81

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Trajectories of growth among children who have coronary events as adults. N Engl J Med (2005) 7.29

Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One (2008) 7.16

Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet (2010) 5.79

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest (2007) 5.02

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet (2008) 4.84

Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet (2006) 4.78

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes (2006) 4.36

Glucose regulation in young adults with very low birth weight. N Engl J Med (2007) 4.35

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes (2008) 4.20

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94

Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87

Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes (2007) 3.84

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology (2009) 3.67

Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest (2008) 3.51

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes (2005) 2.99

Genetic prediction of future type 2 diabetes. PLoS Med (2005) 2.98

Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes (2009) 2.96

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes (2005) 2.82

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73

A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60

Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet (2006) 2.60

Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes (2004) 2.52